Opioids produces 42 documented subjective effects across 5 categories.
Full Opioids profileThe opioid class produces its characteristic effects through activation of mu, delta, and kappa opioid receptors. The subjective experience is dominated by profound analgesia, euphoria, and sedation in proportions that vary across the class.
The core opioid experience involves a warm, enveloping euphoria that radiates from the center of the body outward. Pain, both physical and emotional, is dissolved. Anxiety vanishes. The world becomes soft, distant, and utterly benign. There is a deep, heavy contentment that makes doing nothing feel like the most rewarding possible activity. The mind enters a dreamy, nodding state where thoughts drift without urgency or distress.
Physically, opioids produce pupil constriction, respiratory depression, constipation, nausea, and itching. The euphoria is powerfully reinforcing, creating one of the strongest addiction liabilities of any drug class. Tolerance develops rapidly. Physical dependence follows with reliable efficiency. Withdrawal is intensely unpleasant, and the cycle of use, tolerance, dependence, and withdrawal defines the lived experience of opioid addiction. The lethal risk lies in respiratory depression, which can prove fatal at doses only modestly above the euphoric threshold, particularly in combination with other depressants.
A slowing or cessation of bowel movements resulting in difficulty passing stool, commonly caused by opioid receptor activation in the gastrointestinal tract and notoriously resistant to tolerance development.
Cough suppressionA decreased desire and need to cough, medically known as antitussive action, which can also allow inhalation of larger amounts of smoke without triggering the cough reflex.
Decreased libidoDecreased libido is a diminished interest in and desire for sexual activity, commonly caused by substances that suppress dopaminergic reward signaling, dampen emotional responsiveness, or induce sedation.
DiarrheaDiarrhea is the occurrence of frequent, loose, or watery bowel movements as a side effect of certain psychoactive substances, resulting from either direct GI irritation or pharmacological alterations to gut motility and fluid absorption.
Difficulty urinatingDifficulty urinating, also known as urinary retention, is the experience of being unable to easily pass urine despite a full bladder, commonly caused by stimulant, opioid, and anticholinergic substances that affect bladder muscle control.
DizzinessA sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, often accompanied by nausea and difficulty standing or walking steadily.
Dry mouthA persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parched, sticky, and difficult to swallow through, commonly known as cottonmouth.
Excessive yawningInvoluntary, repeated yawning that occurs far more frequently than normal and often without the usual association with tiredness or boredom. The yawns may be deep and extended, sometimes occurring in rapid succession, and can be accompanied by watery eyes and a brief sense of stretching release throughout the face and jaw.
HeadacheA painful sensation of pressure, throbbing, or aching in the head that can range from a dull background discomfort to a debilitating pounding that dominates awareness. Substance-induced headaches may occur during the acute effects, during the comedown, or as a rebound symptom hours to days after use.
Increased heart rateA noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a forceful, rapid pounding felt throughout the chest, neck, and temples. This effect is among the most commonly reported physiological responses to psychoactive substances and often accompanies stimulation, anxiety, or physical exertion during intoxication.
ItchinessA persistent, diffuse urge to scratch the skin that arises without any external irritant, most commonly caused by opioid-induced histamine release, ranging from a mild tingling to an intense, widespread crawling sensation across the body.
Motor control lossA distinct decrease in the ability to control one's physical body with precision, balance, and coordination, ranging from minor clumsiness to complete inability to walk.
Muscle relaxationThe experience of muscles throughout the body losing their rigidity and tension, becoming noticeably relaxed, loose, and comfortable.
NauseaAn uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting, often occurring during the onset phase of many substances.
Orgasm suppressionOrgasm suppression (anorgasmia) is the difficulty or complete inability to achieve orgasm despite adequate sexual stimulation, commonly caused by opioids, dissociatives, SSRIs, and stimulants through mechanisms including tactile suppression, serotonergic excess, and altered CNS signaling.
Pain reliefA suppression of negative physical sensations such as aches and pains, ranging from dulled awareness of discomfort to complete inability to perceive pain.
Physical euphoriaAn intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity, or a full-body orgasmic glow radiating outward from the core. This effect is often described as one of the most rewarding physical sensations available through psychoactive substances and is a primary driver of the recreational appeal of many substance classes.
Pupil constrictionA visible narrowing of the pupil diameter (miosis) that reduces the size of the dark center of the eye to a small pinpoint. This effect is one of the most reliable physical indicators of opioid intoxication and is often the first sign noticed by medical professionals and observers when assessing someone under the influence of opioids or certain other substance classes.
Respiratory depressionA dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions in respiratory rate to life-threatening cessation of breathing. This is the primary mechanism of death in opioid overdoses and represents one of the most critical safety concerns across all of psychopharmacology.
SedationA state of deep physical and mental calming that manifests as a progressive desire to remain still, lie down, and eventually drift toward sleep. Sedation ranges from a gentle drowsy relaxation to a heavy, irresistible pull into unconsciousness where maintaining wakefulness becomes a losing battle against the body's insistence on shutdown.
SeizureUncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threatening medical emergency requiring immediate help.
Spontaneous physical movementsSpontaneous physical movements are involuntary, seemingly random yet patterned body movements — twitches, swaying, gestures, or full-body undulations — that appear to arise from and correspond to the individual's internal cognitive and sensory experience rather than from conscious motor commands.
StimulationA state of heightened physical and mental energy characterized by increased wakefulness, elevated motivation, and a subjective sense of vigor that pervades both body and mind. Users often report feeling electrically alive, with a buzzing readiness to move, talk, and engage that can range from a pleasant caffeine-like lift to an overwhelming, jittery compulsion to act.
Stomach crampStomach cramps are sharp, intermittent pains in the abdominal region that can occur when psychoactive substances irritate the gastrointestinal lining or alter the normal patterns of smooth muscle contraction in the digestive tract.
VasodilationVasodilation is the relaxation and widening of blood vessels, leading to increased blood flow, reduced blood pressure, and visible effects such as flushing and bloodshot eyes, most commonly associated with cannabinoids, nitrites, and alcohol.
The visual experience of seeing a single object as two separate, overlapping images, similar to crossing one's eyes, ranging from subtle ghosting to complete inability to perceive fine detail.
Internal hallucinationVivid, detailed visual experiences perceived within an imagined mental landscape that can only be seen with closed eyes, ranging from fleeting imagery and abstract scenes to fully immersive, dream-like environments with autonomous narratives and entities.
Visual acuity suppressionVision becomes blurred, indistinct, and out of focus, as though looking through a smudged lens. Fine details degrade and edges lose their definition and sharpness.
A complete or partial inability to form new memories or recall existing ones during and after substance use, ranging from minor gaps in recollection to total blackouts encompassing hours of experience.
AnxietyIntense feelings of apprehension, worry, and dread that can range from a subtle background unease to overwhelming panic attacks with a sense of impending doom, often amplified by the substance's intensification of one's existing mental state.
Anxiety suppressionA partial to complete suppression of anxiety and general unease, producing a calm, relaxed mental state free from worry. This can range from subtle tension relief to a profound sense of inner peace and emotional security.
Cognitive euphoriaA cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as a profound mental contentment and positive outlook. This ranges from gentle feelings of optimism and warmth to overwhelming bliss that pervades all thoughts and perceptions.
Compulsive redosingAn overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maintain or intensify its effects, often overriding rational judgment and self-control.
DepressionA persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasure in activities, often occurring during comedowns, withdrawal, or as a prolonged after-effect of substance use.
DisinhibitionA marked reduction in social inhibitions, self-consciousness, and behavioral restraint that manifests as increased openness, talkativeness, and willingness to engage in activities one would normally avoid. Users often describe feeling as though an invisible social barrier has been lifted, allowing thoughts and impulses to flow directly into action without the usual filtering process.
Dream potentiationEnhanced dream vividness, complexity, and recall, often occurring as REM rebound after discontinuing REM-suppressing substances.
Emotion suppressionA blunting or flattening of emotional experience in which feelings become muted, distant, or seemingly absent. The individual may recognize intellectually that they should be feeling something in response to a situation — joy at good news, sadness at a loss, anxiety about a threat — yet the emotional charge simply is not there, as though an invisible pane of glass separates them from their own feelings.
Motivation enhancementA heightened sense of drive, ambition, and willingness to accomplish tasks, making productive effort feel rewarding and almost effortless.
SleepinessA progressive onset of drowsiness, heaviness, and the desire to sleep that pulls the individual toward rest with increasing insistence. The eyelids feel weighted, the body sinks into whatever surface supports it, cognitive activity winds down into a pleasant fog, and the transition from waking consciousness toward sleep begins to feel not only appealing but inevitable.
Thought decelerationThe experience of thoughts occurring at a markedly reduced pace, as if the mind has been placed into slow motion. Internal dialogue becomes sparse and sluggish, with each idea taking longer to form and process, producing a sense of mental heaviness or cognitive inertia.
Opioids can produce 26 physical effects including tactile suppression, sedation, pain relief, cough suppression, and 22 more.
Yes. Opioids can produce 3 visual effects including visual acuity suppression, double vision, internal hallucination.
Opioids produces 12 cognitive effects including anxiety suppression, thought deceleration, sleepiness, emotion suppression, and 8 more.